Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease.
Fabry disease
OCTA parameters
lysosomal storage disorder
optical coherence tomography angiography (OCTA)
vessel density
vessel length density
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
24 Mar 2023
24 Mar 2023
Historique:
received:
28
12
2022
revised:
27
02
2023
accepted:
16
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Fabry disease (FD) is a potentially lethal lysosomal disorder with systemic vascular changes. Previous studies demonstrated retinal vascular involvement using optical coherence tomography angiography (OCTA) in affected patients; Aim: To analyze and quantify the retinal vasculature measuring vessel density (VD), vessel length density (VLD), and the ratio of VD to VLD (VD/VLD) in superficial capillary plexuses (SCP) and deep capillary plexuses (DCP) using OCTA in patients with FD and to show whether they differ from healthy controls (HC); Patients and methods: Single-center, retrospective, consecutive cohort study of patients with genetically proven FD. Patients underwent an ophthalmological examination including OCTA. VD, VLD, foveal avascular zone (FAZ), and the VD/VLD were compared to an HC group using a linear mixed model; Results: A statistically significant difference in the VLD and VD/VLD of DCP was observed between the two groups (
Sections du résumé
BACKGROUND
BACKGROUND
Fabry disease (FD) is a potentially lethal lysosomal disorder with systemic vascular changes. Previous studies demonstrated retinal vascular involvement using optical coherence tomography angiography (OCTA) in affected patients; Aim: To analyze and quantify the retinal vasculature measuring vessel density (VD), vessel length density (VLD), and the ratio of VD to VLD (VD/VLD) in superficial capillary plexuses (SCP) and deep capillary plexuses (DCP) using OCTA in patients with FD and to show whether they differ from healthy controls (HC); Patients and methods: Single-center, retrospective, consecutive cohort study of patients with genetically proven FD. Patients underwent an ophthalmological examination including OCTA. VD, VLD, foveal avascular zone (FAZ), and the VD/VLD were compared to an HC group using a linear mixed model; Results: A statistically significant difference in the VLD and VD/VLD of DCP was observed between the two groups (
Identifiants
pubmed: 37046445
pii: diagnostics13071227
doi: 10.3390/diagnostics13071227
pmc: PMC10093750
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Novartis Pharma CH AG
ID : (unrestricted research grant)
Références
Annu Rev Genomics Hum Genet. 2012;13:307-35
pubmed: 22970722
Br J Ophthalmol. 2017 Sep;101(9):1193-1200
pubmed: 28057649
Clin Genet. 2016 Jan;89(1):44-54
pubmed: 25974833
J Clin Med. 2020 Jun 02;9(6):
pubmed: 32498362
Klin Monbl Augenheilkd. 2022 Apr;239(4):513-517
pubmed: 35472795
Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2667-2675
pubmed: 31242288
JAMA. 2001 Jun 6;285(21):2743-9
pubmed: 11386930
Ophthalmic Paediatr Genet. 1985 Apr;5(3):185-90
pubmed: 3934620
Prog Retin Eye Res. 2018 May;64:1-55
pubmed: 29229445
Lasers Med Sci. 2022 Feb;37(1):269-277
pubmed: 33409749
Eur J Ophthalmol. 2021 Jan;31(1):158-165
pubmed: 31617414
Acta Ophthalmol. 2020 Aug;98(5):e563-e569
pubmed: 31773840
Sci Rep. 2021 Sep 29;11(1):19381
pubmed: 34588594
Int Ophthalmol. 2020 Nov;40(11):3023-3032
pubmed: 32607948
Int J Retina Vitreous. 2017 May 15;3:13
pubmed: 28515959
J Clin Med. 2020 Dec 18;9(12):
pubmed: 33352849
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
J Clin Med. 2019 Apr 17;8(4):
pubmed: 30999633
J Biomed Opt. 2016 Jun 1;21(6):66008
pubmed: 27286188
Rheumatology (Oxford). 2021 Dec 1;60(12):5827-5832
pubmed: 33715001
J Clin Med. 2021 Mar 05;10(5):
pubmed: 33807900
Contrib Nephrol. 2001;(136):174-92
pubmed: 11688379
J Am Soc Nephrol. 2018 Sep;29(9):2265-2278
pubmed: 30093456
Diagnostics (Basel). 2021 Apr 29;11(5):
pubmed: 33947000
PLoS One. 2020 Dec 8;15(12):e0243236
pubmed: 33290417
Eur J Ophthalmol. 2021 Nov;31(6):3231-3237
pubmed: 33225739
Expert Opin Biol Ther. 2004 Jul;4(7):1167-76
pubmed: 15268683
Klin Monbl Augenheilkd. 2022 Apr;239(4):523-526
pubmed: 35472797
Br J Ophthalmol. 2007 Feb;91(2):210-4
pubmed: 16973664
Ann Intern Med. 2003 Feb 18;138(4):338-46
pubmed: 12585833
Ophthalmologica. 1978;176(6):313-30
pubmed: 211468
Retina. 2017 Mar;37(3):592-603
pubmed: 28225726
Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1299-1306
pubmed: 34800139
Ophthalmology. 1991 May;98(5 Suppl):741-56
pubmed: 2062510
Int J Cardiol. 2017 Dec 15;249:261-267
pubmed: 28964554
Surv Ophthalmol. 2008 Jul-Aug;53(4):416-23
pubmed: 18572058
Acta Ophthalmol. 2013 Mar;91(2):e113-9
pubmed: 23164241
Acta Ophthalmol (Copenh). 1981 Oct;59(5):674-82
pubmed: 6797229
Mol Genet Metab Rep. 2019 Feb 06;19:100454
pubmed: 30775256
PLoS One. 2021 Feb 25;16(2):e0247399
pubmed: 33630902
Diagnostics (Basel). 2020 Jun 17;10(6):
pubmed: 32560526
JAMA. 1999 Jan 20;281(3):249-54
pubmed: 9918480
J Clin Med. 2021 Sep 16;10(18):
pubmed: 34575289
J Clin Med. 2021 Oct 23;10(21):
pubmed: 34768406
Curr Med Chem. 2018;25(13):1530-1537
pubmed: 28618999
Diagnostics (Basel). 2021 Dec 20;11(12):
pubmed: 34943635
Am J Ophthalmol. 2016 Jan;161:160-71.e1-2
pubmed: 26476211
J Med Genet. 2015 May;52(5):353-8
pubmed: 25795794
J Ophthalmol. 2020 Sep 21;2020:2650873
pubmed: 33029387
Acta Diabetol. 2017 Jul;54(7):695-702
pubmed: 28474119
JAMA Ophthalmol. 2015 Jan;133(1):45-50
pubmed: 25317632